Rho Bio

Private

New Haven, ConnecticutHealthcare & Life Scienceshttps://www.rho.bio/

Last Round

Grant

Apr 1, 2026

Company Overview

Rho Bio is a biotechnology company that develops protein-engineered lymphatic activators to treat diseases caused by lymphatic dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein engineeringlymphatic systembiologicstherapeutic developmentdirected evolutioninvestigational new drugINDVEGFR3lymphedema treatmentneuro-ophthalmic diseasepre-clinical biotechdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rho Bio Comparables

Compare Rho Bio with similar companies based on industry and business-model similarity.

Rho Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Ropirio Therapeutics	79%
Herantis Pharma Oyj	73%
SteerBio	73%

View all Comparables

Rho Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2026
Pre Seed	Apr 7, 2025

View all Funding Rounds

Rho Bio Investors

Notable investors and investment history

Rho Bio investors
Investor	Rounds
Connecticut Innovations	Seed
Ono Venture Investment, Inc.	Pre Seed
Mission BioCapital	Seed, Pre Seed

View all Investors

Rho Bio Filings

Explore SEC and related filing metadata, where available.

Rho Bio filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersNew Haven, Connecticut

Employee Range3

Year Founded2024

Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?